The Lancelot technology delivers enhanced hemodynamics through the integration of precision laser cutting and after ...

The FDA approved the Trilogy Transcatheter Heart Valve System for the treatment of symptomatic severe aortic regurgitation, device maker JenaValve Technology announced. This approval makes Trilogy the ...

With its FDA approval, JenaValve intends to commence launch activity for the Trilogy System immediately with participating ...

Six studies in collaboration with Mayo Clinic confirm the UltraSight™ Echosystem enables non-expert clinicians to ...

The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.

JenaValve's Trilogy System, FDA-approved for severe AR, offers secure anchoring without calcium. It is a breakthrough for ...

Doctors at a Delhi private hospital performed a minimally invasive cardiac procedure on a pre-term newborn barely 40 minutes after birth, r.

Newborn with critical heart condition undergoes successful invasive procedure in Delhi hospital | Latest News Delhi ...

PVAD IQ integrates into existing ultrasound workflows as part of UltraSight™’s Echosystem, an AI-powered software platform designed to guide healthcare professionals in performing high-quality cardiac ...

Results From The International MISSION Re-BEAT Feasibility Trial Using A Pulsatile, Soft Robotic Biventricular MCS Device That Avoids Blood Contact In Heart Failure Patients With Reduced Ejection ...

Heleven Mezerene, an active person and busy nurse, was born with a heart valve defect that would one day need surgery. “I discovered this diagnosis when I was in my early thirties because I used to ...

A new study on aortic stenosis, the most common form of heart valve disease, has identified more than 200 new genes that predispose individuals to this condition, for which no treatment currently ...